U.S. Senator Cindy Hyde-Smith @SenHydeSmith
By removing in-person dispensing requirements for mifepristone, @US_FDA is disregarding women's health. A recent study found the rate of ER visits post chemical abortion was up by more than 500% from 2002-2015. FDA must strengthen the REMS to protect women’s health. @boblatta — PolitiTweet.org